UBS Group AG - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 224 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$189,103
-93.8%
22,647
-90.2%
0.00%
-100.0%
Q2 2023$3,060,091
-66.4%
230,082
-70.7%
0.00%
-66.7%
Q1 2023$9,098,105
+2005.1%
785,674
+1387.0%
0.00%
Q4 2022$432,191
-7.1%
52,835
-34.1%
0.00%
Q3 2022$465,000
+165.7%
80,185
+102.3%
0.00%
Q2 2022$175,000
-80.2%
39,631
-59.2%
0.00%
Q1 2022$885,000
-56.7%
97,222
-2.8%
0.00%
-100.0%
Q4 2021$2,046,000
-26.9%
99,982
-8.7%
0.00%0.0%
Q3 2021$2,799,000
-48.5%
109,552
-29.5%
0.00%
-50.0%
Q2 2021$5,431,000
+87.7%
155,308
+78.8%
0.00%
+100.0%
Q1 2021$2,894,000
+34.6%
86,880
+4.8%
0.00%0.0%
Q4 2020$2,150,000
+476.4%
82,884
+119.2%
0.00%
Q3 2020$373,000
+213.4%
37,805
+9.1%
0.00%
Q2 2020$119,000
-73.6%
34,640
-76.5%
0.00%
Q1 2020$451,000
-92.4%
147,482
-87.3%
0.00%
-100.0%
Q4 2019$5,967,000
-27.1%
1,160,945
-26.8%
0.00%
-33.3%
Q3 2019$8,180,000
-18.1%
1,585,152
-3.9%
0.00%
-25.0%
Q2 2019$9,983,000
-10.8%
1,650,010
+6.6%
0.00%
-20.0%
Q1 2019$11,188,000
-21.2%
1,547,494
-19.4%
0.01%
-16.7%
Q4 2018$14,202,000
+434.7%
1,919,173
+290.9%
0.01%
+500.0%
Q3 2018$2,656,000
+91.5%
490,927
+25.6%
0.00%0.0%
Q2 2018$1,387,000
+124.1%
390,816
+29.5%
0.00%
Q1 2018$619,000
+34.3%
301,726
+72.8%
0.00%
Q4 2017$461,000
-68.1%
174,614
-36.6%
0.00%
-100.0%
Q3 2017$1,445,000
+258.6%
275,301
+143.1%
0.00%
Q2 2017$403,000
-31.2%
113,235
-0.2%
0.00%
Q1 2017$586,000
-97.4%
113,501
-98.1%
0.00%
-100.0%
Q4 2016$22,138,000
+2957.7%
5,825,792
+7113.0%
0.01%
Q3 2016$724,000
-9.3%
80,768
-28.8%
0.00%
-100.0%
Q2 2016$798,000
+1146.9%
113,398
+1408.4%
0.00%
Q1 2016$64,000
-50.0%
7,518
-23.1%
0.00%
Q4 2015$128,000
+481.8%
9,771
+57.2%
0.00%
Q3 2015$22,000
-58.5%
6,215
-32.3%
0.00%
Q2 2015$53,000
+178.9%
9,176
+186.8%
0.00%
Q1 2015$19,000
-5.0%
3,200
+28.0%
0.00%
Q4 2014$20,0002,5000.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q3 2022
NameSharesValueWeighting ↓
HAVENS ADVISORS LLC 638,000$4,613,0004.46%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 6,064,035$43,843,000,0003.34%
STANSBERRY ASSET MANAGEMENT, LLC 1,022,262$7,391,0002.54%
HighVista Strategies LLC 378,479$2,736,0002.23%
Versor Investments LP 3,117,632$22,540,0002.14%
BARDIN HILL MANAGEMENT PARTNERS LP 1,627,677$11,768,0001.84%
ORACLE INVESTMENT MANAGEMENT INC 1,110,666$8,030,0001.71%
Magnetar Financial LLC 8,217,938$59,416,0001.53%
ALPINE ASSOCIATES MANAGEMENT INC. 6,072,459$43,905,0001.45%
WATER ISLAND CAPITAL LLC 7,247,354$52,398,0001.43%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders